P DucLOs. Evaluation of immunization coverage in the adult population of Canada. Can J Infect Dis 1994;5(5):227-231. The immunization coverage of the adull population, availabili ty of records and knowledge of proper sched ul es were assessed using the Canada Omnibus Survey. a door lo door survey of a modified probabili ty sample conducted four limes a year. In lola!, 8021 interviews were completed over four periods. Only 43o/o of individuals 65 years of age or o lder reported receiving a dose of influenza vaccine during the year preceding lhe interview. Twenty-one pe•· cenl (38o/o of those under 25 and 9o/o of those 65 and older) reported having an immunization booklet al home. Twelve per cenl believed thal there were no vaccines thal they shou ld be receiving regu larly. On ly 61 o/o of those who believed they should receive some shols regu la rly knew when the nexl one was d u e. Overall . 48o/o fc lllhey had enough information aboullhe vaccines they should receive . This inf01·mation wi ll help largel immunization programs for the adult population. 
DUCLOS

C
ANADIA IMMUNIZATION PROGRAMS FOCUS 0 INFANTS
and ch ildren. Immunization of adu lts, however. is often overlooked and remains an inexpensive and costeffective measure for preventing the morta lity and serious morbidity lhal is associated with infec tious diseases that are vaccine preventable ( 1) . The Nationa l Advisory Committee on Immuniza tion (NACI) (2) recommends that: adults receive a te ta nus-diphtheria (Tel) booster every 10 years: persons ove r 65 years of age receive one dose of pneumococcal vaccine; and persons over 65 years of age receive influenza vaccine every year. Proper immunization with vaccines against diseases such as yellow fever. typhoid. meningococcal meningitis. hepatitis B. measles. mumps. rubella. poliomyelitis and Japanese encep ha liti s viru s is a lso recommended for travellers a nd other specific high risk groups.
Monitoring vaccination coverage is of prime importance to assess the impact of im munization programs and to help improve survei lla nce of adverse vaccine reactions. Although it is acknowledged lhal vaccination is underused in the elderly (3) . there is a general lack of information on immunization coverage of adu lts in Canada . Only one national survey examined lhe coverage with influenza vaccine (4) . There is a lso a n eed to assess the availability of immunization records. These a llow assessm ent of vaccine coverage and h elp ensure that vaccin a tion is timely. Immunization records a lso facilitate the work of health care providers who determine which vaccine shou ld be admin istered .
This study was, therefore. undertaken primarily lo obtain an initial assessment of lhe immunization status of Canadians 18 years of age and older.
PATIENTS AND METHODS
Questions were added to lhe "Focu s Canada Omnibus Survey .. . Th is door to door household survey of a modified probabili ty sample is cond u c ted four limes a year by Environics Research Lld, Toronto. The sample taken represents th e Canadian population aged 18 years and older . with the exception of those li ving in Yukon or the Northwest Territories and those in the armed forces and various institutions (eg. hospitals. prisons). Accor ding to lhe 1992 poslcensal estimates (5) lhe target population numbers around 20 .5 million. of which approximately 3 mill ion are over 65 years of age. The sampling mod el relies on stratification of lhe popula tion by 10 regions (AUanlic; Montreal Census Metropolitan Area [CMA ] ; the rest of Quebec; Toronto CMA: the rest of Ontario: Manitoba: Saskatchewan: Alberta: Vancouver CMA: and the rest of British Columbia) and by four communi ty sizes (1 .000.000 inhabitants or more; 100.000 to 1.000,000 inhabitants; 5000 lo 100,000 inhabitants; and fewer than 5000 inhabitants). The sample also relies on quolas for sex. age and working status for women. Interviewees refusing to pa rticipate were replaced by others 228 with the same ch a racteristics up lo achievement of quota for each group.
On ly one respondent was interviewed per hou sehold. Interviews were condu cted in French or Engli sh according lo the choice of the interviewee. The survey was condu c ted four limes during the year to achi eve sufficient sample size a nd to account for seasonal variation. Questions included history and type of immunization (including all vaccines they might have received) during the yea r before the interview. availability of immunization records and perceived knowledge of immunization practices. The questionnaires were distributed. through regional supervisors. to approximately 150 experienced interviewers across the country. A s how card with names of a ll vaccines (and alternate names) was used lo help intervi ewees remember vaccines that they may have received . To check the quality of lhc work completed and the accu racy of the ind icated responses. 10% of each interviewer's respondents were re-contacted lo con firm participation in the questionnaire and that the questionna ire was admini stered properly. Answers given by respondents in these interviews had lo correspond with answers given at lhe lime of lhe interview or the interview was discarded along with other interviews conducted by the intervi ewer involved. Data entered into lhe computer were weighted according to the actual population of each of lhc regions. Other proprie ta ry questions were included in lhc various cycles for clients other than Health Canada. Content of lhe questions was not related lo health and s h ou ld nol have h ad an impact on immuni zationrelated questions .
The effects of several demographic variables were evalu ated, including age, sex, region of residency and community size. number of years of school completed . occ upa tion a nd household income.
Ninety-five per cent C IS were calculated using the normal approximation (6) . Estimated proportions in excess of 0.5% were rounded lo the nearest integer.
Analysis compared results from one cycle of the study with the other to detect seasonal trends and to assess consistency in the results. For general analysis. and s ince sampling was independent from one cycle to the other, data from all four cycles were pooled together and treated as a unique sample.
Information on the vaccine distribution per calendar year was obtained from and released with the agreement of lhe manufacturers. 31 to 37) of persons who received their last shot at a clinic. Thirty-four per cent (95% CI 32 to 36) of interviewees indicated that they had received their last vaccine at the office of their personal or family doctor, 27% (95% CI 25 to 29) at school, 14% (95% CI 12 to 16) in a hospita l, 14% (95% CI 12 to 16) a t a clinic, 4% (95% CI 3 to 5) somewhere else. while 7% (95% CI 6 to 8) did not remember where and 1% (95% CI 0 to 2) indicated they had n ever been vaccinated.
RESULTS
A total of 8021 interviews was completed
Because administration of influenza vaccine is directly rela ted to a particular season, only the third study cycle conducted in February and March 1992 was used to evaluate coverage of this vaccine during the fall-winter 1991-92 immunization campaign. Th e interviews were conducted soon after the immuniza tion campaign; therefore, recollection was probably more vivid and pertinent to that season. Overall , 11 % (95% CI 10 to 13) of the population 18 years of age and older stated they r eceived inOuenza vaccine during the previous year (ie, received during the 1991 -92 inOu en za vaccine campaign). In the age group 18 t.o 44 years, only 3% (95% C l 2 to 4) stated they received a dose versus 14% (95% Cl 11 to 1 7) of those 45 to 64 years and 43% (95% C I 37 to 49) of those 65 years and older.
For other vaccines, all cycles were pooled together for analysis. Despite some variations in the estimates over the four cycles, no seasonal variation was detected in the use of yellow fever, typhoid and cholera vaccines. This could be because these vaccines are most likely exclusively administered to travellers , and because of the size of the C IS and low proportion of people receiving them . No seasonal variation could be observed for the other vaccines .
Overall, 0.25% of respondents and 1% of those 65 years and older stated they received pneumococcal vaccine during the year before the interview . Based on the size of the popu lation 18 years and older , this indicates that nearly 51.000 vaccine doses were given.
One per cent (95% CI 0 to 2) of all interviewees stated they received polio vaccine (oral or inactivated) during the year before the interview. This would account for nearly 210 ,000 doses a year being administered.
An estimated 6% (95% C l 5 to 7) of a dults stated th ey received either Td or Td with pertussis (TdP). This would account for 1,234.000 doses annually. This vaccine was received by 9% of those persons 18 to 24 years of age, 7% of those 25 to 34 years. 5% of those 35 to 44 years, 4% of those 45 to 54 years, 4% of those 55 to 64 years and 3% of those 65 years of age and older . Thirty-six per cent of tetanus vaccines were received in a hospital setting. Only 2% (95% CI 1 to 3) of adults indicated receiving diphth eria vaccine the previous year.
According to the rep li es, an estimated 2% (95% C I 1 to 3) of the adult population stated they received the hepatitis B vaccine. This would account. for 369,000 doses. For persons 18 to 24 years of age, 2.6% stated they had received the vaccine versus 3.4% of those 25 to 34 years: 1.9% of th ose 35 to 44: 2.1% of those 45 to 54; 0.8% of those 55 to 64; and 0.2% of those 65 years of age and older.
An estimated 0 .5% of the adult population stated they received the typhoid vaccine. This wou ld account. for 95,000 doses. An estima ted 0.35% of adults received th e cholera vaccine. Th is would be equivalent to 72,000 doses. An estimated 0.27% received the yellow fever vaccine. accounting for 55,500 doses .
The average numbers of doses of selected vaccines distributed in Canada in 1991 and 1992 appear in Table 2 .
DISCUSSION
Advantages of using such a survey to look at vaccine coverage are: first , the quick turnaround time (six to eight weeks) for results; second, use of an ongoing study that permits the evaluation of the impact of various demographic vari ables: a nd third , limited cost for well targeted questions.
Our study tried lo lake advantage of the personal recollection of an event by asking interviewees wh ich vaccines they had received during the previous year instead of the date on which they had received specific vaccines during the same time period . Timely immunization coverage figures or compliance figu res regar ding NACI recommendations could be derived from knowing wh ich vaccines were received during the year before the interview. This is particularly easy for vaccines lhal are a dministered annually. such as the influenza vaccine. Vaccines recommended by NACI to be given only every 10 years, such as Td. can be obtained by multiplying the proportion of persons receiving their dose on a given year by 10. Ideally. with vaccines, such as pneumococcal vaccine , given only once, one should just have to consider people turning 65 years of age. However, due to the low use of this vaccine, this is not feasible . Nevertheless, because of such a low coverage as noted in our survey, one can probably rely on broad figures and on the number of doses distributed. The need to account for seasonality, the problems inherent in th e lack of immunization records and the need to rely on persona l recollection a re the disadvantages of indirect evaluation of coverage.
As no definition was provided to them, it was left to th e interviewees to define regular use for vaccines they shou ld be receiving. This may h ave introduced some subj ectivity in the responses to the question pertaining to the vaccines that interviewees should be receiving regularly because people may estimate that receiving vaccine every 10 years, for example, does not mean regularly.
Although Table 1 shows that the situation is not equal in all provinces and regions, and it may be tempting to infer that there is an east-west grad ient, it is important. to refrain from drawing such a conclusion. Within a region there may be provincial differences.
Differences m ay reflect different traditions or different vaccine delivery systems.
Recollection of receipt of lhe tetanus vaccine was much h igher lhan receipt of diphtheria (although a mere 17% of vaccine doses distributed for adull use contain only the lelanus antigen). indicating lhal people may receive Td or TdP vaccine wilhoul realizing lhey are being immunized against diphtheria. This resu lts from a lack of information or from associating only lelanus as being administered fo llowing an injury. Although globulins should always be accompanied by a lelanus booster, in practice this is nol a lways lhe case. People may confuse administration of immune globulins. which procures passive immunity. wilh administration of lhe vaccine when treated for a wound. This is further supported by lhe large propOI-tion of vaccine doses administered in a hospital selling.
The same confusion between vaccine and globulins also app lies lo lhe hepatitis B vaccine. Three doses are req uired for primary vaccination. However. according lo lhe replies and assuming persons were rece iving one dose only. more doses would h ave been used lhan are currently distributed.
Wilh lhe exception of vaccines for which the re may b e some confusion with administration of globulins (such as h e patitis B and tetanus) or for whic h a major lack of information exists (such as diphtheria), and wilhin the limits of the Cis , lhe res ults seem quile valid. In particular they would generally agree wilh vaccine distribution figures.
Resu lts suggest the need lo improve coverage and lo improve awareness aboul immunization in lhe adu lt popu lation . Our results indicate lhal a maximum of 60% of adults would comply wilh NACI recommendations of a booster dose of lelanus every l 0 years. Furthermore, a booster is often given after exposure as opposed lo parl of a routine immunization. This is demonstrated by the proportion of doses given in hospital settings. It is particularly striking lo realize lh al more doses of yellow fever vaccine are b eing administered than doses of lhe pneumococcal vaccine. Our resu lts regarding lhe influenza vaccine are consislenl wilh lhe findings using the more precise bul complicated methodology of lhe General Social Survey (4). We used lhe spring cycle lo assess influenza vaccine coverage lo minimize recall bias. A Vaccine coverage of adults in Canada cycle with summer cycle resu lts can determine whether reca ll bias was imporlanl. The spring cycle results are only 1% higher than the summer cycle results . It is nevertheless difficult lo know if lhis difference is a rea l difference or merely due to chance. It is definitively nol statistically significan l.
The very lim ited availabili ty of immunization records emphasizes how difficult il would b e to evaluate vaccine coverage in adults directly. Th e results suggest poor vaccine coverage, poor immunization record keeping. poor awareness of immunization, and thal these problems are not specific with in a subgroup but that there is a general lack of interest or education about a dult immunization in U1e general popu lation. Some groups such as younger males and those with lower educa tion and/or income levels s h ou ld be particularly targeted by information campaigns or educational activities. Should education and promotion efforts be undertaken, a similar meth odology cou ld be usefu l in measuring progress accomplished in record keeping and awareness. We recommend using such studies to monitor evolution of vaccine coverage with the influenza vaccine. For vaccines rarely used. such as travellers· vaccines and pneumococcal vaccines. one could rely on lhe monitoring of vaccine distribution.
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